Literature DB >> 17025247

Chitosan lactate as a nonviral gene delivery vector in COS-1 cells.

Wanlop Weecharangsan1, Praneet Opanasopit, Tanasait Ngawhirunpat, Theerasak Rojanarata, Auayporn Apirakaramwong.   

Abstract

The purpose of this research was to evaluate chitosan lactate (CL) of different molecular weights (MWs) as a DNA complexing agent for its efficiency in transfecting COS-1 cells (green monkey fibroblasts) and its effect on cell viability compared with polyethylenimine (PEI), a commercially available cationic polymer. CL and chitosan base dissolved in dilute acetic acid (chitosan acetate [CA]) of different MWs (20, 45, 200, 460 kDa) and N/P ratios (2:1, 4:1, 8:1, 12:1, 24:1) formed complexes with pSV beta-galactosidase plasmid DNA. The complexes were characterized by agarose gel electrophoresis and investigated for their ability to transfect COS-1 cells compared with PEI. Additionally, the effect of CL on the viability of COS-1 cells was investigated using 3-(4,5-dimethyliazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The binding of CL/DNA and CA/DNA was dependent on chitosan MWs. The N/P ratio of CL to completely form the complex with the DNA was higher than that of CA. Both CL and CA were comparable in transfection efficiencies at an N/P ratio of 12:1, but less efficient than PEI (P < .05). The cell viability in the presence of CL and CA at all MWs was over 90%, whereas that of PEI-treated cells was approximately 50%. These results suggest the advantage of CL for in vitro gene transfection, with the ease of preparation of polymer/DNA complexes and low cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17025247      PMCID: PMC2750508          DOI: 10.1208/pt070366

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  26 in total

1.  Chitosan-based nanoparticles for topical genetic immunization.

Authors:  Z Cui; R J Mumper
Journal:  J Control Release       Date:  2001-08-10       Impact factor: 9.776

Review 2.  Chitosan as a novel nasal delivery system for vaccines.

Authors:  L Illum; I Jabbal-Gill; M Hinchcliffe; A N Fisher; S S Davis
Journal:  Adv Drug Deliv Rev       Date:  2001-09-23       Impact factor: 15.470

Review 3.  Latest development in viral vectors for gene therapy.

Authors:  Kenneth Lundstrom
Journal:  Trends Biotechnol       Date:  2003-03       Impact factor: 19.536

Review 4.  Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy.

Authors:  Sania Mansouri; Patrick Lavigne; Karin Corsi; Mohamed Benderdour; Eric Beaumont; Julio C Fernandes
Journal:  Eur J Pharm Biopharm       Date:  2004-01       Impact factor: 5.571

5.  In vitro gene delivery mediated by chitosan. effect of pH, serum, and molecular mass of chitosan on the transfection efficiency.

Authors:  T Sato; T Ishii; Y Okahata
Journal:  Biomaterials       Date:  2001-08       Impact factor: 12.479

6.  Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures.

Authors:  Bogdan I Florea; Clare Meaney; Hans E Junginger; Gerrit Borchard
Journal:  AAPS PharmSci       Date:  2002

7.  In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer.

Authors:  Futoshi Shikata; Hiroyuki Tokumitsu; Hideki Ichikawa; Yoshinobu Fukumori
Journal:  Eur J Pharm Biopharm       Date:  2002-01       Impact factor: 5.571

8.  Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines.

Authors:  M Thanou; B I Florea; M Geldof; H E Junginger; G Borchard
Journal:  Biomaterials       Date:  2002-01       Impact factor: 12.479

9.  Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.

Authors:  Tae Hee Kim; In Kyu Park; Jae Woon Nah; Yun Jaie Choi; Chong Su Cho
Journal:  Biomaterials       Date:  2004-08       Impact factor: 12.479

10.  Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles.

Authors:  Karin Corsi; Fatiha Chellat; L'Hocine Yahia; Julio C Fernandes
Journal:  Biomaterials       Date:  2003-03       Impact factor: 12.479

View more
  6 in total

1.  Effects of spray drying on physicochemical properties of chitosan acid salts.

Authors:  Mirna Fernández Cervera; Jyrki Heinämäki; Nilia de la Paz; Orestes López; Sirkka Liisa Maunu; Tommi Virtanen; Timo Hatanpää; Osmo Antikainen; Antonio Nogueira; Jorge Fundora; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2011-05-11       Impact factor: 3.246

Review 2.  Advances in polymeric and inorganic vectors for nonviral nucleic acid delivery.

Authors:  Joel C Sunshine; Corey J Bishop; Jordan J Green
Journal:  Ther Deliv       Date:  2011-04

3.  Chitosan-thiamine pyrophosphate as a novel carrier for siRNA delivery.

Authors:  Theerasak Rojanarata; Praneet Opanasopit; Sunee Techaarpornkul; Tanasait Ngawhirunpat; Uracha Ruktanonchai
Journal:  Pharm Res       Date:  2008-06-18       Impact factor: 4.200

4.  Chitosan-mediated siRNA delivery in vitro: effect of polymer molecular weight, concentration and salt forms.

Authors:  Sunee Techaarpornkul; Sirirat Wongkupasert; Praneet Opanasopit; Auayporn Apirakaramwong; Jurairat Nunthanid; Uracha Ruktanonchai
Journal:  AAPS PharmSciTech       Date:  2010-01-08       Impact factor: 3.246

5.  Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles.

Authors:  Farhad Jadidi-Niaragh; Fatemeh Atyabi; Ali Rastegari; Esmail Mollarazi; Melika Kiani; Alireza Razavi; Mehdi Yousefi; Nasim Kheshtchin; Hadi Hassannia; Jamshid Hadjati; Fazel Shokri
Journal:  Tumour Biol       Date:  2016-01-05

6.  Application of ferriferous oxide modified by chitosan in gene delivery.

Authors:  Yu Kuang; Tun Yuan; Zhongwei Zhang; Mingyuan Li; Yuan Yang
Journal:  J Drug Deliv       Date:  2012-12-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.